TCM Intrinsic Value

TCMLMTD • Chemicals
Current Stock Price
₹43.90
Primary Intrinsic Value
₹36.25
Market Cap
₹35.1 Cr
-17.4% Downside
Median Value
₹36.25
Value Range
₹28 - ₹36
Assessment
Trading Above Median Value
Safety Margin
-21.1%

TCMLMTD Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹36.25 ₹32.62 - ₹39.88 -17.4% Book Value/Share: ₹36.25, P/B: 1.0x
Revenue Multiple Method revenue ₹28.00 ₹25.20 - ₹30.80 -36.2% Revenue/Share: ₹35.00, P/S: 0.8x
Method Types: Earnings Asset DCF Growth Dividend Conservative

Valuation Comparison Chart

TCMLMTD Intrinsic Value Analysis

What is the intrinsic value of TCMLMTD?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of TCM (TCMLMTD) is ₹36.25 (median value). With the current market price of ₹43.90, this represents a -17.4% variance from our estimated fair value.

The valuation range spans from ₹28.00 to ₹36.25, indicating ₹28.00 - ₹36.25.

Is TCMLMTD undervalued or overvalued?

Based on our multi-method analysis, TCM (TCMLMTD) appears to be trading above median value by approximately 17.4%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Debt to Equity Ratio 2.62 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity -13.8% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -14.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.37x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-10 Cr ₹-10 Cr Negative Cash Flow 3/10
March 2024 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2023 ₹-11 Cr ₹-11 Cr Negative Cash Flow 3/10
March 2022 ₹-4 Cr ₹-4 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹-1 Cr Negative Cash Flow 3/10